You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Thromboresistant vascular grafts:heparin-peptidomimetics
SBC: BIOSURFACE ENGINEERING TECHNOLOGIES Topic: N/AThrombosis of synthetic vascular grafts is a major problem with current grafts that necessitates prophylaxis, can lead to loss of patency with an attendant need for repeat surgery, and comes with a high risk of limb loss. The applicant proposes to develop thromboresistant extended polytetrafluoroethylene (ePTFE) vascular grafts that use an absorbed coating of heparin to control acute and subacute ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Resuscitating Blood-Substituted Hypothermic Dogs
SBC: BioTime, Inc. Topic: N/ADESCRIPTION (provided by applicant): Currently, due to high morbidity and mortality, the use of hypothermic circulatory arrest (HCA) is limited to only the most difficult surgical cases. During HCA, the body receives no perfusion, oxygen, or energy supply. Our goal is to develop technology to achieve hours rather than minutes of HCA during which extensive traumatic injuries and currently "unres ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Development of Lysosomal Modulatory Drugs to Treat Alzheimer's Disease
SBC: SYNAPTIC DYNAMICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Reducing protein deposition events is essential for slowing the progression of Alzheimer's disease (AD), especially A 1-42 peptide oligomers that accumulate inside and outside neurons and cause functional compromise. Finding a strategy to reduce A oligomeric assemblies is widely thought to be the key objective for treating AD. Accumulation of A peptides is on ...
STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health -
Web-based Empowerment Program for Disaster Victims and First Responders
SBC: BLUESUN, INC. Topic: N/ADESCRIPTION (provided by applicant): This project will support research and further development of a novel commercializable product designed to reduce and mitigate the psychological impact of a major disaster. The long-term objective of this project is to provide a scientifically supported, highly accessible, culturally relevant, anonymous multi- media system that fills the current gap in mental ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Development of a peptide array synthesis system
SBC: Boston Array Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): The overall goal of phase I and II of this proposal is to develop microarray-based methods for high throughput profiling of proteins. This will be done in two different ways, one based on arrays of 100s of thousands of distinct peptides on 1 cm2 chips that can be used to fingerprint proteins, the other based on thousands or tens of thousands of antibodies again ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Design of an Automated Psoriasis Treatment System
SBC: Boston Array Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): Up to 3 percent of populations worldwide have psoriasis. A large number of the patients with psoriasis can be treated using UV light exposure. We propose to employ a light modulating microchip based on recent Micro Electro Mechanical Systems (MEMS) technological developments to build an Automated Psoriasis Treatment System. The overall goal of Phase I a ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: BOSTON MEDICAL PRODUCTS, INC. Topic: N/AN/A
STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF A MIDDLE EAR BALLOON IMPLANT
SBC: BOSTON MEDICAL PRODUCTS, INC. Topic: N/ADESCRIPTION (provided by applicant): Development of a new type of middle ear implant, a "middle ear balloon" is proposed. This implant is intended to restore hearing in non-aerated ears by creating and permanently maintaining an air or gas-filled space within the middle ear. Non-aerated middle ears resulting from eustachian tube dysfunction camonly occur in chronic otitis media (COM) and in otitis ...
STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF A MIDDLE EAR BALLOON IMPLANT
SBC: BOSTON MEDICAL PRODUCTS, INC. Topic: N/ADESCRIPTION (provided by applicant): Development of a new type of middle ear implant, a "middle ear balloon" is proposed. This implant is intended to restore hearing in non-aerated ears by creating and permanently maintaining an air or gas-filled space within the middle ear. Non-aerated middle ears resulting from eustachian tube dysfunction camonly occur in chronic otitis media (COM) and in otitis ...
STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
Multifunctional Carriers for Systemic siRNA Delivery
SBC: SURFAGEN, INC. Topic: N/ADESCRIPTION (provided by applicant): The objectives of this research project are to design and develop safe and efficient multifunctional delivery systems for systemic and target-specific delivery of small interfering RNA (siRNA) to treat human diseases with RNA interference (RNAi). RNAi is a natural mechanism for gene silencing and has a great potential to treat human disease by turning off speci ...
STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health